Virtual Lifestyle Medicine Group Visits for High Blood Pressure
A Scalable, Lifestyle Medicine Intervention for Hypertension Using Virtual Group Shared Medical Appointments
1 other identifier
interventional
18
1 country
1
Brief Summary
The purpose of this study is to learn whether virtual Lifestyle medicine shared medical appointments (LMSMAs) can help people better manage their blood pressure and improve their overall health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Aug 2026
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedStudy Start
First participant enrolled
August 3, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2027
Study Completion
Last participant's last visit for all outcomes
February 7, 2027
July 13, 2026
July 1, 2026
5 months
July 6, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in diastolic blood pressure readings
2-4 weeks after randomization,6 months after randomization
Change in systolic blood pressure readings
2-4 weeks after randomization,6 months after randomization
Secondary Outcomes (5)
Percentage of eligible participants who agree to participate
end of study (6 months after randomization)
Number of primary care physicians (PCPs) whose patients are included in the program
end of study (6 months after randomization)
Median number of sessions attended by each participant
end of study (6 months after randomization)
Adherence as assessed by the number of of blood pressure (BP) readings submitted between each session
end of study (6 months after randomization)
Adherence to home BP monitoring as assessed by the number of of home BP sessions submitted between each session
end of study (6 months after randomization)
Study Arms (2)
Lifestyle Medicine Virtual Group Visit Program plus usual medical care
EXPERIMENTALUsual medical care only
ACTIVE COMPARATORInterventions
Participants will be given a home BP monitor upon enrollment and the group will engage in twice monthly virtual shared medical appointments (vSMAs) for 4 visits. Prior to each visit, participants will be asked to complete home BP monitoring (twice in the morning and twice in the evening for 3 days before visit), with readings reviewed during visits and medications adjusted as clinically indicated. Participants will complete four sessions over an 8-week period, with one session type offered in each 2 week block.
Participants will be given a home BP monitor upon enrollment and will be instructed by phone and with an electronic health record (EHR) portal message on proper technique for home BP readings. Participants will continue to have follow-up visits with their PCP as clinically indicated.
Eligibility Criteria
You may qualify if:
- Current diagnosis of hypertension (ICD codes I10.0-I14.0 billed within the last 5 years Essential HTN, Essential HTN, Primary HTN)
- Currently receives care at a UTPhysicians; Last seen by a PCP at Victory location within the last 1 year.
- Able to participate in a virtual format
- Willingness to participate and engage in home blood pressure monitoring
You may not qualify if:
- Unstable cardiovascular disease (recent Myocardial Infarction (MI), unstable angina, decompensated HF)
- Advanced Chronic kidney disease (CKD) (eGFR \< 30) without nephrology co-management
- Active cancer treatment
- Severe cognitive impairment (unable to engage)
- Uncontrolled psychiatric illness (e.g., active psychosis)
- Resistant hypertension (requiring\> 3 medications at maximum doses)
- Unable to participate in English class format
- Unstable internet or lack of smartphone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Puja B Gandhi, MD, MPH, DipABLM
The University of Texas Health Science Center, Houston
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 6, 2026
First Posted
July 13, 2026
Study Start (Estimated)
August 3, 2026
Primary Completion (Estimated)
January 3, 2027
Study Completion (Estimated)
February 7, 2027
Last Updated
July 13, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share